Skip to main content
. 2021 Feb 26;104(4):1516–1518. doi: 10.4269/ajtmh.20-1484

Table 1.

Clinical performance of COVID-19 Nucleic Acid Test Kit (eDiagnosis) and 2019-nCoV Nucleic Acid Diagnostic Kit (Sansure Biotech) using the CDC protocol as a gold standard (% values: sensitivity)

RT-PCR kit Positive samples False-negative samples Total SARS-CoV-2–positive samples
COVID-19 Nucleic Acid Test Kit (eDiagnosis) 43 (100%) 0 43
2019-nCoV Nucleic Acid Diagnostic Kit (Sansure Biotech) 41 (95.3%) 2 43

Only SARS-CoV-2–positive samples included on the study are detailed.